What Works Skin — Independent · Evidence-First · Ad-FreeIssue 014 · 20 April 2026 · Next: 04 Maywhatworksskin.com

Product · Cleanser · Trend pick

P. 20 · REVIEW

Minimalist · Cleansers

Coffee 1% Cleanser.

marketing dressed as evidence.

Coffee at 1% is too low to do anything mechanically (no scrub) and far too low to deliver meaningful caffeine to skin. The cleanser base is ordinary; the brand name is the active ingredient. There are better picks at the same price.

— § 01

The scorecard.

Surfactant gentleness
Mild blend, but no remarkable barrier protection.
17⁄25
Active claim integrity
1% coffee in a rinse-off is a graphics decision, not a formula.
8⁄25
pH alignment
5.5 — at least the basics are right.
21⁄25
Value
₹ 350 / 100 mL — equal to better-formulated peers.
12⁄25

— § 03

When to reach for it.

  • Pleasant daily cleanse

    If you like the smell and the price. Evidence — none beyond a clean base.

  • Brand-curious users

    Use it as a gentle daily cleanser. Don't expect the coffee to do anything.

  • Sample-sized travel use

    100 mL packs well. That's the only real edge.

— § 05

Frequently asked.

Doesn't caffeine do something for puffiness?

Yes — when applied as a leave-on at 3-5%, with hours of contact. In a 30-second rinse-off at 1%, it does nothing.

Is it a bad cleanser?

No — the base is fine. It just isn't the coffee that's working; it's the same surfactant blend you'd buy elsewhere for less.

Why a C tier, not D?

Because the formula won't harm your skin. D is reserved for products that actively mislead with potentially harmful claims (e.g. plant stem cells).

Better Indian alternates?

At ₹ 300-400: Plum Green Tea Pore Cleansing Face Wash. At ₹ 500-700: CeraVe / Cetaphil. Both deliver more for the rupee.

— § 06

Sources consulted.

  1. REVIEWHerman A, Herman AP. Caffeine's mechanisms of action. Skin Pharmacol Physiol 2013.On /sources →
  2. MECHANISMOtberg N et al. Topical penetration kinetics of caffeine. Int J Cosm Sci 2008.On /sources →
  3. TEXTBOOKSurber C, Davis AF. Bioavailability and bioequivalence of dermatological formulations. CRC Press 2011.On /sources →